Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Almorexant in chronic primary insomnia (RESTORA 1)
NCT00608985Phase 3Completed
- Sponsor
- Midnight Pharma
- Start
- Mar 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of almorexant in Insomnia, sponsored by Midnight Pharma. Started Mar 2008; status: completed.
02
Drugs
almorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00608985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608985.